Copyright
©The Author(s) 2022.
World J Gastroenterol. May 21, 2022; 28(19): 2034-2056
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2034
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2034
Table 1 Demographic characteristic of cases with suspected coronavirus disease 2019-attributed acute pancreatitis
| Patient characteristics | Value |
| Age, median (range, yr) | 42.0 (6-87) |
| Gender, male/female/NA | 37/44/1 |
| Comorbidities | |
| Hypertension | 22 |
| Diabetes | 15 |
| Dyslipidemia | 4 |
| Heart disease | 3 |
| Cerebrovascular | 0 |
| Respiratory disease | 4 |
| Renal dysfunction | 5 |
| Obesity | 16 |
| Pregnancy | 2 |
| Malignancy | 2 |
| History of abdominal surgery | 13 |
| Others | 10 |
| Alcohol consumption, none/low/heavy/NA | 53/9/0/20 |
| History of smoking, never/experience/current/NA | 32/2/0/48 |
| Severity of COVID-19 | |
| Non-severe/severe/critical/NA | 35/23/20/4 |
| Symptoms | |
| Fever | 49 |
| Breath shortness | 16 |
| Cough | 28 |
| Dyspnea | 18 |
| Sore throat | 18 |
| Fatigue | 9 |
| Headache | 7 |
| Myalgia | 10 |
| Anorexia | 13 |
| Diarrhea | 16 |
| Abdominal pain | 75 |
| Nausea | 39 |
| Vomiting | 48 |
| Others | 23 |
| Blood test | |
| WBC, median (range, × 103/mm3) | 13.10 (3.40-230.00) |
| PLT, median (range, × 103/mm3) | 235.5 (52.0-502.0) |
| D-Dimer, median (range, μg/mL) | 4.9 (0.3-17.7) |
| Amylase, median (range, U/L) | 635 (47-4530) |
| Lipase, median (range, U/L) | 895.5 (35.6-11920.0) |
| LDH, median (range, U/L) | 366.0 (170-3553) |
| CRP, median (range, mg/dL) | 8.5 (0.3-59.7) |
| Imaging findings (n = 75) | |
| Pancreatic enlargement | 42 |
| Peripancreatic fluid collection | 33 |
| Peripancreatic inflammatory change | 48 |
| Pancreatic ischemic change | 12 |
| No change of pancreas | 6 |
| Not visualized | 2 |
| Severity of acute pancreatitis | |
| Mild/moderate/severe/NA | 28/20/28/6 |
| Therapy for COVID-19 | |
| Lopinavir/ritonavir | 4 |
| Favipiravir | 4 |
| Umifenovir | 2 |
| Remdesivir | 8 |
| Hydroxychloroquine | 2 |
| Tocilizumab | 2 |
| Corticosteroid (n = 53) | 21 |
| Oxygen therapy (n = 69) | 42 |
| Mechanical ventilation | 19 |
| Therapy for acute pancreatitis | |
| Conservative therapy/surgical drainage/NA | 72/4/6 |
| Period of hospitalization, median (range, day) | 7.5 (2-76) |
| Prognosis | |
| Alive/death/NA | 69/10/3 |
Table 2 Baseline characteristics of cases with coronavirus disease 2019 and acute pancreatitis coexistent
| Case No. | Ref. | Age | Gender | Diagnostic evidence for SARS-CoV-2 | Severity of COVID-19 | Abdominal pain | Amylase/lipase (IU/L) | Abdominal image findings | Modality of image | Severity of acute pancreatitis | Treatment for pancreatitis | Prognosis |
| 1 | Anand et al[70] | 59 | Female | RT-PCR | Non-severe | Presence | NA/NA | Diffuse pancreatic enlargement | CT | Mild | Conservative | Alive |
| 2 | Hadi et al[71] | 47 | Female | RT-PCR | Critical | Absence | 1500/NA | Diffuse pancreatic enlargement | AUS | Severe | NA | NA |
| 3 | Hadi et al[71] | 68 | Female | RT-PCR | Critical | Presence | 934/NA | NA | NA | Severe | NA | NA |
| 4 | Aloysius et al[72] | 36 | Female | RT-PCR | Critical | Presence | 325/627 | No change | CT | Severe | Conservative | Alive |
| 5 | Miao et al[73] | 26 | Female | RT-PCR | Non-severe | Presence | NA/430 | Diffuse pancreatic enlargement | CT | NA | NA | Alive |
| 6 | Szatmary et al[74] | 29 | Male | RT-PCR | Non-severe | Presence | 77/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 7 | Szatmary et al[74] | 47 | Male | RT-PCR | Non-severe | Presence | 211/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 8 | Rabice et al[75] | 36 | Female | RT-PCR | Severe | Presence | 88/875 | Not visualized | AUS | Mild | Conservative | Alive |
| 9 | Alloway et al[76] | 7 | Female | RT-PCR | Non-severe | Presence | NA/1672 | Diffuse pancreatic enlargement | AUS and CT | Mild | Conservative | Alive |
| 10 | Karimzadeh et al[77] | 65 | Female | RT-PCR | Severe | Presence | 285/294 | No change | CT | Mild | Conservative | Alive |
| 11 | Gonzalo-Voltas et al[78] | 76 | Male | RT-PCR | Non-severe | Presence | 3568/NA | Diffuse pancreatic enlargement | CT | Moderate | Conservative | Alive |
| 12 | Bokhari et al[79] | 32 | Male | RT-PCR | Non-severe | Presence | 672/721 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Mild | Conservative | Alive |
| 13 | Mazrouei et al[80] | 24 | Male | RT-PCR | Non-severe | Presence | 391/578 | Enlargement of pancreatic tail, peripancreatic fluid collection | CT | Mild | Conservative | Alive |
| 14 | Ahmed et al[81] | 47 | Male | RT-PCR | Severe | Presence | 349/NA | Peripancreatic inflammatory change | CT | Severe | NA | Alive |
| 15 | Brikman et al[82] | 61 | Male | RT-PCR | Severe | Presence | 142/203 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 16 | Kataria et al[83] | 49 | Female | RT-PCR | Severe | Presence | 501/1541 | Diffuse pancreatic enlargement, peripancreatic fluid collection | CT | Mild | Conservative | Alive |
| 17 | Cerda-Contreras et al[84] | 72 | Female | RT-PCR | Severe | Absence | 1789/1247 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Severe | Conservative | Dead |
| 18 | Cheung et al[85] | 38 | Male | RT-PCR | Non-severe | Presence | NA/338.7 | Acute pancreatitis | CT | NA | Conservative | Alive |
| 19 | Kumaran et al[86] | 67 | Female | RT-PCR | Severe | Presence | 1483/NA | Peripancreatic inflammatory change and fluid collection, non-enhancement of most of the head and proximal body | CT | Severe | Conservative | Alive |
| 20 | Purayil et al[87] | 58 | Male | RT-PCR | Non-severe | Presence | 249/NA | Not visualized | AUS | Mild | Conservative | Alive |
| 21 | Dietrich et al[88] | 72 | Male | RT-PCR | Critical | Presence | NA/185 | Normal pancreas | CT | Mild | NA | Alive |
| 22 | Patnaik et al[89] | 29 | Male | RT-PCR | Non-severe | Presence | 2861/1650 | Diffuse pancreatic enlargement, peripancreatic fluid collection | CT | Mild | Conservative | Alive |
| 23 | Wang et al[90] | 42 | Male | RT-PCR | Critical | Presence | 132/382 | Pancreatic enlargement, peripancreatic fluid collection | CT | Moderate | Conservative | Dead |
| 24 | Wang et al[90] | 35 | Male | RT-PCR | Non-severe | Presence | NA/1042 | Pancreatic enlargement, peripancreatic fluid collection | CT | Moderate | Conservative | Alive |
| 25 | Alves et al[91] | 56 | Female | RT-PCR | Critical | Presence | 544/2993 | Dffuse pancreatic enlargement, peripancreatic inflammatory change | CT and MRI | Severe | Conservative | Alive |
| 26 | Kurihara et al[92] | 55 | Male | RT-PCR | Critical | Absence | 252/263 | Pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
| 27 | Lakshmanan and Malik[93] | 68 | Male | RT-PCR | Non-severe | Absence | 1030/2035 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 28 | Samies et al[94] | 15 | Male | RT-PCR | Non-severe | Presence | NA/233 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 29 | Samies et al[94] | 11 | Male | RT-PCR | Non-severe | Presence | 215/953 | No change | CT | Mild | Conservative | Alive |
| 30 | Samies et al[94] | 16 | Female | RT-PCR | Non-severe | Presence | NA/1909 | Pancreatic enlargement | CT | Mild | Conservative | Alive |
| 31 | Fernandes et al[95] | 36 | Female | RT-PCR | NA | Presence | 710/640 | Pancreatic enlargement, peripancreatic fluid collection | CT | Moderate | Conservative | Alive |
| 32 | Stevens et al[55] | 10 | Female | Serological IgG | Severe | Presence | NA/1371 | Peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
| 33 | Shinohara et al[96] | 58 | Male | RT-PCR | Critical | Presence | 795/NA | Diffuse pancreatic enlargement peripancreatic inflammatory change | CT | Moderate | Conservative | Alive |
| 34 | Meyers et al[97] | 67 | Male | RT-PCR | NA | Presence | NA/5295 | Interstitial edematous pancreatitis peripancreatic inflammatory change | CT | Moderate | NA | NA |
| 35 | Ghosh et al[98] | 63 | Male | RT-PCR | Severe | Absence | 58/412 | Focal pancreatic enlargement, peripancreatic fluid collection | CT | NA | Conservative | Alive |
| 36 | Tollard et al[99] | 32 | Female | RT-PCR | Critical | Presence | NA/321 | Diffuse pancreatic enlargement peripancreatic inflammatory change | CT | Severe | Conservative | Dead |
| 37 | Kandasamy et al[100] | 45 | Female | RT-PCR | Severe | Presence | 364/293 | Diffuse pancreatic enlargement, peripancreatic inflammatory change and fluid collection | CT | Moderate | Conservative | Alive |
| 38 | Hassani et al[101] | 78 | Female | RT-PCR | Critical | Presence | 1200/1450 | Pancreatic enlargement necrotizing pancreatitis | AUS and CT | Severe | Conservative | Dead |
| 39 | Suchman et al[56] | 10 | Female | RT-PCR | Non-severe | Presence | NA/365.7 | NA | NA | Moderate | Conservative | Alive |
| 40 | Suchman et al[56] | 16 | Male | RT-PCR | Critical | Presence | NA/233.3 | NA | NA | Severe | Conservative | Alive |
| 41 | Narang et al[102] | 20 | Female | RT-PCR | Severe | Presence | 1168/916 | Acute pancreatitis | MRI | Severe | Conservative | Alive |
| 42 | Acherjya et al[103] | 57 | Female | RT-PCR | Severe | Presence | 80/8352 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Moderate | Conservative | Alive |
| 43 | Alwaeli et al[104] | 30 | Male | RT-PCR | Critical | Presence | 151/1022 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
| 44 | Simou et al[105] | 67 | NA | RT-PCR | Severe | Absence | NA/576 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Dead |
| 45 | Jespersen Nizamic et al[106] | 49 | Female | RT-PCR | Non-severe | Presence | NA/2864 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 46 | Abraham et al[107] | 61 | Female | RT-PCR | Non-severe | Presence | NA/1018 | NA | NA | Mild | Conservative | Alive |
| 47 | Abhinay et al[108] | 13 | Female | RT-PCR | NA | Presence | 217/365 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 48 | Bouali et al[109] | 60 | Female | RT-PCR | Critical | Presence | NA/627 | Peripancreatic fluid collection | CT | Severe | Drainage of abdominal cavity, total gasterectomy | Dead |
| 49 | Alharmi et al[110] | 52 | Female | RT-PCR | Non-severe | Presence | 47/NA | Atrophic pancreas, peripancreatic inflammatory change, peripancreatic fluid collection | CT | Moderate | Conservative | Alive |
| 50 | Abbas et al[57] | 13 | Female | RT-PCR | Critical | Presence | 217.8/NA | Fluid collection | CT | Severe | Conservative | Alive |
| 51 | Bineshfar et al[111] | 14 | Male | RT-PCR | Non-severe | Presence | 1914/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 52 | Paz et al[112] | 14 | Male | RT-PCR | Non-severe | Presence | 196/247 | Peripancreatic inflammatory change, fluid collection | MRI | Mild | Conservative | Alive |
| 53 | Wifi et al[113] | 72 | Female | RT-PCR | Non-severe | Presence | 1667/710 | No change | CT | Mild | Conservative | Alive |
| 54 | Sandhu et al[114] | 25 | Female | RT-PCR | Critical | Presence | 350/35.6 | Diffuse pancreatic enlargement | CT | Severe | Conservative | Dead |
| 55 | Mohammadi Arbati et al[115] | 28 | Male | RT-PCR | Critical | Presence | 1273/758 | Peripancreatic inflammatory change, fluid collection, acute necrotic pancreatitis | CT | Severe | Conservative | Alive |
| 56 | Amé et al[116] | 42 | Female | RT-PCR | NA | Presence | 2263/2799 | Pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | NA | Conservative | Alive |
| 57 | Gupta et al[117] | 25 | Female | RT-PCR | Severe | Presence | 1814/11920 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Severe | Conservative | Alive |
| 58 | Muhammad Abrar Jeelani et al[118] | 24 | Male | RT-PCR | Non-severe | Presence | NA/4174 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 59 | Maalouf et al[119] | 62 | Male | RT-PCR | Non-severe | Presence | NA/4361 | Peripancreatic inflammatory change, necrotic collection | MRI | Moderate | Conservative | Alive |
| 60 | Sanchez et al[120] | 16 | Male | RT-PCR | Severe | Presence | NA/961 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 61 | Ehsan et al[121] | 13 | Female | RT-PCR | Severe | Presence | 598/2331 | Peripancreatic inflammatory change, fluid collection | CT | Moderate | Conservative | Alive |
| 62 | Hanif et al[122] | 30 | Female | RT-PCR | Severe | Presence | 820/626 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
| 63 | Chandra et al[123] | 53 | Male | RT-PCR | Critical | Presence | NA/1200 | Peripancreatic inflammatory change | CT | Severe | Conservative | Alive |
| 64 | Alfishawy et al[124] | 17 | Male | RT-PCR | Severe | Absence | 285/273 | Pancreatic loculations | CT | Moderate | Conservative | Alive |
| 65 | Berrichi et al[125] | 36 | Female | RT-PCR | Critical | Presence | NA/2570 | Diffuse pancreatic enlargement, peripancreatic inflammatory change | CT | Severe | Conservative | Dead |
| 66 | Berrichi et al[125] | 51 | Female | RT-PCR | Severe | Presence | NA/676 | Diffuse pancreatic enlargement | CT | Mild | Conservative | Alive |
| 67 | Kripalani et al[126] | 79 | Female | RT-PCR | Critical | Presence | 1075/6178 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, acute necrotic pancreatitis | CT | Severe | Cycto-jejunostomy | Alive |
| 68 | Narayan et al[127] | 28 | Male | RT-PCR | Critical | Presence | Elevated/elevated | Diffuse pancreatic enlargement, peripancreatic inflammatory change and acute necrotic pancreatitis | CT | Severe | Conservative | Dead |
| 69 | Narayan et al[127] | 45 | Female | RT-PCR | Severe | Presence | Elevated/elevated | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 70 | Eldaly et al[128] | 44 | Male | RT-PCR | Non-severe | Presence | 773/286 | Diffuse pancreatic enlargement | CT | Mild | Conservative | Alive |
| 71 | Basukala et al[129] | 49 | Female | RT-PCR | Non-severe | Presence | 1563/568 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection, necrotic pancreatitis | CT | Severe | Gastrocolic ligament and followed by necrotic debridement, and drainage placement | Dead |
| 72 | Schembri Higgans et al[130] | 63 | Female | RT-PCR | Non-severe | Presence | 1079/NA | After Whipple surgery | CT | Mild | Conservative | Alive |
| 73 | Schembri Higgans et al[130] | 87 | Female | RT-PCR | Non-severe | Presence | 499/NA | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 74 | Schembri Higgans et al[130] | 64 | Female | RT-PCR | Non-severe | Presence | 2141/NA | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
| 75 | Kopiczko et al[131] | 6 | Female | RT-PCR | Non-severe | Presence | 1124/4250 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Mild | Conservative | Alive |
| 76 | Kareva et al[58] | 11 | Male | Serological IgG | Non-severe | Presence | 489/576 | Edematous appendix no change of pancreas | AUS | NA | Conservative | Alive |
| 77 | da Costa Ferreira et al[132] | 35 | Male | RT-PCR | Severe | Presence | 1669/NA | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection normal gallbladder and biliary tract | CT | Severe | Conservative | Alive |
| 78 | Sánchez-Gollarte et al[133] | 60 | Male | Serological IgG | Severe | Presence | 4530/2220 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection, necrotic pancreatitis | CT | Severe | Drainage of abdominal cavity | Alive |
| 79 | Sudarsanam et al[134] | 35 | Male | RT-PCR | Non-severe | Presence | Normal/normal | Peripancreatic inflammatory change, fluid collection, necrotic pancreatitis of tail | CT | NA | Conservative | Alive |
| 80 | Faghih Dinevari et al[135] | 18 | Female | RT-PCR | Non-severe | Presence | 1288/1541 | Diffuse pancreatic enlargement, peripancreatic inflammatory change, fluid collection | CT | Mild | Conservative | Alive |
| 81 | Goldstein et al[136] | 11 | Male | Serological IgG | Severe | Presence | 1607/2434 | Peripancreatic inflammatory change, fluid collection, necrotic pancreatitis | MRI | Moderate | Conservative | Alive |
| 82 | Gadiparthi et al[137] | 74 | Female | RT-PCR | Non-severe | Presence | 229/7550 | Peripancreatic inflammatory change | CT | Mild | Conservative | Alive |
Table 3 The probability of other etiologies of acute pancreatitis in cases with coronavirus disease 2019 and acute pancreatitis coexistent
| Case No. | Alcohol | Biliary | Hypertrig | Drug | Acute aggravati | Hypercal | Infection | Ischemia/reperfusi | Trauma/ anatomy | Genetics | MIS-C/PIMS |
| 1 | N | ? | ? | Y | N | ? | ? | N | N | - | - |
| 2 | N | N1 | N | ? | N | N | ? | Y | N | - | - |
| 3 | ? | ? | N | ? | N | N | ? | Y | N | - | - |
| 4 | N | N | N | N | N | ? | ? | N | N | - | - |
| 5 | N | N | N | N | N | N | N2 | N | N | - | - |
| 6 | N | N | N | N | N | ? | ? | ? | N | - | - |
| 7 | N | N | N | N | N | ? | ? | ? | N | - | - |
| 8 | N | N | N | N | N | ? | ? | N | N | - | - |
| 9 | N | ? | ? | N | N | ? | ? | N | N | ? | N |
| 10 | ? | N | N | N | N | N | ? | N | N | - | - |
| 11 | N | N | ? | Y | N | ? | ? | N | N | - | - |
| 12 | N | N | N | N | N | N | ? | N | N | - | - |
| 13 | N | N | ? | N | N | ? | ? | N | N | - | - |
| 14 | ? | Y | ? | Y | N | ? | ? | N | N | - | - |
| 15 | N | N | N | Y | N | N | ? | N | N | - | - |
| 16 | N | N | N | Y | N | N | ? | N | N | - | - |
| 17 | ? | ? | N | Y | N | N | ? | Y | N | - | - |
| 18 | N | N | N | N | N | N | ? | N | N | - | - |
| 19 | N | N | N | N | N | N | ? | N | N | - | - |
| 20 | N | N | ? | N | N | ? | ? | N | N | - | - |
| 21 | N | N | ? | N | N | ? | ? | N | N | - | - |
| 22 | N | N | N | N | N | N | ? | N | N | - | - |
| 23 | N | N | N | N | N | N | ? | N | N | - | - |
| 24 | N | N | N | N | N | N | ? | N | N | - | - |
| 25 | N | N | N | N | N | N | ? | N | N | - | - |
| 26 | ? | N | N | Y | N | N | ? | Y | N | - | - |
| 27 | N | N | N | N | N | N | ? | N | N | - | - |
| 28 | N | ? | N | N | N | ? | ? | N | N | N | N |
| 29 | N | N | N | N | N | ? | ? | N | N | N | ? |
| 30 | N | Y | N | N | Y | ? | ? | N | N | N | N |
| 31 | N | N1 | ? | N | N | ? | ? | N | N | - | - |
| 32 | N | Y | N | N | N | ? | ? | N | N | ? | Y |
| 33 | N | N | N | Y | N | N | ? | Y | N | - | - |
| 34 | N | N | N | N | N | ? | ? | N | N | - | - |
| 35 | N | ? | ? | ? | N | ? | ? | N | N | - | - |
| 36 | N | Y | N | N | N | N | ? | Y | N | - | - |
| 37 | N | N | ? | N | N | ? | ? | N | N | - | - |
| 38 | N | N | N | N | N | N | ? | N | N | - | - |
| 39 | N | ? | ? | ? | N | ? | ? | ? | ? | ? | Y |
| 40 | N | ? | ? | ? | N | ? | ? | ? | ? | ? | N |
| 41 | N | N | N | Y | N | ? | ? | Y | N | - | - |
| 42 | N | N | N | Y | N | N | ? | N | N | - | - |
| 43 | N | N | N | N | N | N | N2 | N | N | - | - |
| 44 | N | N | N | Y | N | N | N2 | Y | N | - | - |
| 45 | N | ? | ? | N | N | ? | ? | N | N | - | - |
| 46 | ? | ? | ? | N | N | N | ? | N | N | - | - |
| 47 | ? | ? | ? | N | N | ? | ? | N | N | ? | N |
| 48 | ? | ? | ? | N | N | ? | ? | N | N | - | - |
| 49 | N | N | N | Y | N | N | ? | N | N | - | - |
| 50 | N | N | N | Y | N | ? | N2 | N | N | N | Y |
| 51 | N | N | ? | N | N | ? | ? | N | N | ? | N |
| 52 | ? | N | N | N | N | ? | ? | N | N | N | N |
| 53 | ? | N | N | N | N | N | ? | N | N | - | - |
| 54 | N | Y | N | N | N | N | ? | N | N | - | - |
| 55 | N | N | N | N | N | N | ? | N | N | - | - |
| 56 | N | N | N | N | N | N | ? | N | N | - | - |
| 57 | N | N | N | ? | N | N | ? | N | N | - | - |
| 58 | N | N | N | N | N | N | ? | N | N | - | - |
| 59 | N | N | N | N | N | ? | ? | N | N | - | - |
| 60 | N | N | ? | N | N | N | ? | N | N | N | N |
| 61 | N | N | N | N | N | ? | ? | N | N | ? | ? |
| 62 | N | ? | N | Y | N | N | N | Y | N | - | - |
| 63 | N | N | N | N | N | ? | ? | N | N | - | - |
| 64 | N | Y | Y | N | N | ? | ? | N | N | ? | ? |
| 65 | ? | N | ? | N | N | ? | ? | N | N | - | - |
| 66 | ? | N | ? | N | N | ? | ? | N | N | - | - |
| 67 | N | N | ? | N | N | ? | ? | N | N | - | - |
| 68 | ? | N | N | Y | N | ? | ? | N | N | - | - |
| 69 | ? | ? | ? | Y | N | ? | ? | Y | N | - | - |
| 70 | N | N | N | N | N | ? | ? | N | N | - | - |
| 71 | N | N | N | N | N | N | ? | N | N | - | - |
| 72 | N | N | ? | N | N | ? | ? | N | Y | - | - |
| 73 | ? | N | N | N | N | ? | ? | N | N | - | - |
| 74 | ? | Y | ? | N | N | ? | ? | N | N | - | - |
| 75 | N | N | N | N | N | N | N | N | N | ? | N |
| 76 | N | N | ? | N | N | N | ? | N | N | ? | Y |
| 77 | N | Y | N | N | N | N | ? | N | N | - | - |
| 78 | ? | N | ? | ? | N | N | ? | N | N | - | - |
| 79 | N | N | N | N | N | N | ? | N | N | - | - |
| 80 | N | N | N | N | N | N | ? | N | N | N | N |
| 81 | ? | ? | ? | Y | N | ? | N2 | N | N | ? | Y |
| 82 | N | N | N | N | N | N | ? | N | N | - | - |
- Citation: Onoyama T, Koda H, Hamamoto W, Kawahara S, Sakamoto Y, Yamashita T, Kurumi H, Kawata S, Takeda Y, Matsumoto K, Isomoto H. Review on acute pancreatitis attributed to COVID-19 infection. World J Gastroenterol 2022; 28(19): 2034-2056
- URL: https://www.wjgnet.com/1007-9327/full/v28/i19/2034.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i19.2034
